Postgraduate Course: Pharmacogenomics (MCLM11012)

Course Outline
School	Deanery of Molecular, Genetic and Population Health Sciences	College	College of Medicine and Veterinary Medicine
Credit level (Normal year taken)	SCQF Level 11 (Postgraduate)
Course type	Online Distance Learning	Availability	Not available to visiting students
SCQF Credits	10	ECTS Credits	5
Summary	Pharmacogenomics is the study of how the genome affects the body's response to drugs. This branch of science holds the promise that drugs might be tailored for individuals and adapted to a patientżs personal makeup, thus improving efficacy and safety. Pharmacogenomics combines traditional pharmaceutical sciences such as biochemistry with specific knowledge of genes, proteins, and single nucleotide polymorphisms. This module is designed to equip candidates with knowledge of the principles, concepts, and practical implications of pharmacogenomics that are relevant to clinical applications.
Course description	Not entered

Entry Requirements (not applicable to Visiting Students)
Pre-requisites		Co-requisites
Prohibited Combinations		Other requirements	None

Course Delivery Information

Academic year 2017/18, Not available to visiting students (SS1)		Quota: None
Course Start	Semester 1
Timetable	Timetable
Learning and Teaching activities (Further Info)	Total Hours: 100 ( Seminar/Tutorial Hours 5, Online Activities 100, Feedback/Feedforward Hours 40, Formative Assessment Hours 12, Summative Assessment Hours 10, Revision Session Hours 8, Programme Level Learning and Teaching Hours 2, Directed Learning and Independent Learning Hours 0 )
Assessment (Further Info)	Written Exam 0 %, Coursework 100 %, Practical Exam 0 %
Additional Information (Assessment)	Online participation: 25% Individual project: 25% Reflective portfolio: 30% Case scenarios: 20%
Feedback	Not entered
No Exam Information

Learning Outcomes
On completion of this course, the student will be able to: Describe and define basic pharmacogenomic concepts and taxonomy Evaluate polymorphism types and their impact on pharmacokinetics (PK) and pharmacodynamics (PD) Explore the implications of the ethical, legal, social and economic issues related to pharmacogenomic testing Identify resources for obtaining current and updated pharmacogenomic information.